SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ACADIA Pharmaceuticals Inc (ACAD)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
588 32 0 ACAD
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
263scaram, could you translate this to ordinary English. Should I smoke it or notfreelyhovering-4/12/2006
262And your point is? ;>)steve kammerer-4/11/2006
261Mol Pharmacol. 2006 Mar 29; [Epub ahead of print] SPHINGOSINE AND ITS ANALOGUEscaram(o)uche-4/10/2006
260they get all the best agonists, plus the maze sounds kinda cool...... the aniscaram(o)uche-3/30/2006
259Ya, mon. Pass the mouse.kenhott-3/30/2006
258from the "well, duh!" department...... J Pharmacol Exp Ther. 2006 Marscaram(o)uche-3/30/2006
257Int J Obes (Lond). 2006 Apr;30 Suppl 1:S33-8. The role of the endocannabinoid scaram(o)uche-3/30/2006
256I would like to know more indepth into Acadia's ACP 103 phase 2 results as Idr.praveen-3/29/2006
255Acadia Shares Slip on Drug-Trial Results Friday March 24, 5:08 pm ET Acadia Phmopgcw-3/25/2006
254Looks pretty solid to me, and the stock is up a bit after hours. Don't knowtuck-3/23/2006
253ACADIA Pharmaceuticals Announces Positive Results From Phase II Trial of ACP-103sim1-3/23/2006
252J Neurosci. 2006 Mar 15;26(11):2991-3001. The CB1 cannabinoid receptor is the scaram(o)uche-3/17/2006
251J Psychopharmacol. 2006 Mar 13; [Epub ahead of print] Effects of the cannabinoscaram(o)uche-3/15/2006
250Neuroscience. 2006 Mar 7; [Epub ahead of print] The CB1 cannabinoid receptor mscaram(o)uche-3/12/2006
249[Serum concentrations of clozapine and norclozapine in the prediction of relapsetuck-3/10/2006
248zacks.com A report on Acadia from Zacks Regards, Praveen PS: I have a moderatdr.praveen-3/7/2006
247Item 1.01. Entry into a Material Definitive Agreement On February 28, 2006,scaram(o)uche-3/6/2006
246BJ on side effect concerns, CB1R antagonists.... Message 22191077 Some know thscaram(o)uche-2/22/2006
245>>Beginning to look as though Dr. Brann has enrolled in the Khosla school tuck-2/21/2006
244forbes.com (snip) <i>Sanofi led shares lower, dropping 1.90 eur or 2.57 scaram(o)uche-2/21/2006
243CB1R antagonist with acomplia just now "approvable"..... delayed, bscaram(o)uche-2/21/2006
242ACADIA Pharmaceuticals Announces Advancements in Two Preclinical Programs Tuesdanigel bates-2/21/2006
241[Pharmacological and behavioral profile of ACP-103, a novel 5-HT2A receptor invetuck-2/14/2006
240NY Times Marilyn and Me: Dealing With Illusions (or Life on a Parkinson's Dkenhott-2/14/2006
239Acadia shares soar after CNBC host's endorsement By Bruce V. Bigelow UNION-sim1-2/1/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News